PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Transfusion Medicine Research, Cerus Corporation, Concord, California, USA.\', \'Department of Physiology and Biophysics, School of Medicine, University of California Irvine, Irvine, California, USA.\', \'Enable Biosciences Inc, South San Francisco, California, USA.\', \'Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA.\', \'Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA.\', \'Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/trf.16819
?:doi
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 35128658
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all